The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2007

Filed:

Aug. 20, 2003
Applicants:

Taeyoung Yoon, Guilford, CT (US);

Ping GE, Durham, CT (US);

Stéphane DE Lombaert, Madison, CT (US);

Raymond F. Horvath, Guilford, CT (US);

Dario Doller, Wallingford, CT (US);

Kevin J. Hodgetts, Kilingworth, CT (US);

LU Yan Zhang, Branford, CT (US);

Bernd Kaiser, Wallingford, CT (US);

Xuechun Zhang, Branford, CT (US);

Yasuchika Yamaguchi, Guilford, CT (US);

Cunyu Zhang, Morrisville, NC (US);

Jim Darrow, Wallingford, CT (US);

Inventors:

Taeyoung Yoon, Guilford, CT (US);

Ping Ge, Durham, CT (US);

Stéphane De Lombaert, Madison, CT (US);

Raymond F. Horvath, Guilford, CT (US);

Dario Doller, Wallingford, CT (US);

Kevin J. Hodgetts, Kilingworth, CT (US);

Lu Yan Zhang, Branford, CT (US);

Bernd Kaiser, Wallingford, CT (US);

Xuechun Zhang, Branford, CT (US);

Yasuchika Yamaguchi, Guilford, CT (US);

Cunyu Zhang, Morrisville, NC (US);

Jim Darrow, Wallingford, CT (US);

Assignee:

Neurogen Corporation, Branford, CT (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/535 (2006.01); A61K 31/497 (2006.01); A61K 31/4965 (2006.01); C07D 413/00 (2006.01); C07D 403/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Novel 5-substituted-2-arylpyrazine compounds are provided. Such compounds can act as selective modulators or CRF receptors. Compounds of the invention are provided by the following formula: The 5-substituted-2-arylpyrazine compounds provided herein are useful in the treatment of a number of CNS and periphercal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided. Compounds provided are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.


Find Patent Forward Citations

Loading…